HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Qian, Y. Articles by Lee, C. Search for Related Content PubMed PubMed Citation Articles by Qian, Y. Articles by Lee, C. Related Collections Proteomics and Protein Markers

Two-dimensional gel electrophoresis detects prostate-specific antigen–₁-antichymotrypsin complex in serum but not in prostatic fluid

¹ Department of Urology, Northwestern University Medical School, Chicago, IL 60611.

² Cancer Research Program, Hybritech, San Diego, CA 92196.
^a Author for correspondence. Fax 312-908-7275; e-mail c-lee7{at}nwu.edu

We investigated the interaction between prostate-specific antigen (PSA) and 1-antichymotrypsin (ACT) in prostatic secretions, identifying PSA and ACT in human serum, prostatic fluid, and seminal plasma by two-dimensional gel electrophoresis (2-D PAGE). Both PSA and ACT were detected in all three body fluids, but PSA-ACT complex was detected only in serum. Moreover, the 2-D PAGE Western blot staining profile for ACT from serum differed from that for prostatic fluid or seminal plasma. Incubation of prostatic fluid with purified ACT led to formation of PSA-ACT complex. Incubation of prostatic fluid with purified PSA, however, failed to form the complex, suggesting that the ACT in prostatic fluid was inactive or inhibited. Given that physiological concentrations of zinc inhibited the formation of PSA-ACT complex, we consider zinc a possible physiological inhibitor of the formation of the PSA-ACT complex. These results indicate that the failure to detect the PSA-ACT complex in prostatic fluid could be related to the inactivation of ACT, the presence of inhibitors (e.g., zinc), or simply the PSA:ACT ratio in the fluid.

Key Words: indexing terms: electrophoresis, polyacrylamide gel • Western blot • prostatic cancer • zinc • complex-formation inhibitors

The following articles in journals at HighWire Press have cited this article:

				K. Jung, J. Reiche, A. Boehme, C. Stephan, S. A. Loening, D. Schnorr, W. Hoesel, and P. Sinha Analysis of Subforms of Free Prostate-Specific Antigen in Serum by Two-Dimensional Gel Electrophoresis: Potential to Improve Diagnosis of Prostate Cancer Clin. Chem., December 1, 2004; 50(12): 2292 - 2301. [Abstract] [Full Text] [PDF]

				P. Nurmikko, K. Pettersson, T. Piironen, J. Hugosson, and H. Lilja Discrimination of Prostate Cancer from Benign Disease by Plasma Measurement of Intact, Free Prostate-specific Antigen Lacking an Internal Cleavage Site at Lys145-Lys146 Clin. Chem., August 1, 2001; 47(8): 1415 - 1423. [Abstract] [Full Text] [PDF]

				P. Nurmikko, V. Vaisanen, T. Piironen, S. Lindgren, H. Lilja, and K. Pettersson Production and Characterization of Novel Anti-Prostate-specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA Clin. Chem., October 1, 2000; 46(10): 1610 - 1618. [Abstract] [Full Text] [PDF]

				R. Ekins and P. Edwards Point On the meaning of ""sensitivity"" Clin. Chem., October 1, 1997; 43(10): 1824 - 1831. [Abstract] [Full Text] [PDF]